Events Partner Content PING Conference 2022 – The Golden Age for Life Sciences Inno... The Golden Age for Life Sciences Innovation
R&D Big pharma vs small diseases: Tackling rare diseases Rare diseases aren’t as rare as the appellation suggests.
Partner Content Partner Content How to Provide Value that Benefits Patients (and Your Brand) Identify opportunities by condition or therapeutic area
R&D Understanding the microbiome as an ‘overlooked critical orga... Compared to a ‘critical organ’ that had been largely ignored, companies working to develop microbiome-based therapies believe there is untapped potential in the area.
Events Partner Content Next Generation RNA Therapeutics Summit Trailblazing Superior RNA Therapeutics of the Future
Partner Content Partner Content KOL Identification & Mapping Driven By Insights Insights captured from KOL interactions represent a new way to identify and map the KOL landscape in which your brand must thrive.
News Relief for AZ as Truqap hits the spot in prostate cancer After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
